Skip to content

Clinical trials

Phase 2 Asthma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 2 Country / region: China Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20173
20181
20201
20225
20232
20246
202510
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed7
Unknown status6
Active, not recruiting3
Not yet recruiting2
Enrolling by invitation2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shanghai University of Traditional Chinese Medicine4
Sanofi3
Akeso2
Anhui Palo Alto Pharmaceuticals, Inc.2
AstraZeneca2
Keymed Biosciences Co.Ltd2
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.2
Amgen1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma29
Airway Obstruction1
Dyspnea1
Lung Diseases1
Pulmonary Eosinophilia1
Respiratory Hypersensitivity1
Respiratory Sounds1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.